More recent approaches have focused on models such as the BLT mouse, which permits systemic reconstitution with human cells [26], supports the formation of HIV latency following HIV infection [42, 43], and maintain persistent reservoirs of virus including latently-infected CD4 + T cells after treatment with clinically relevant ART regimens [42–45]. This evidence concerns the gene CD4 and HIV infectious disease.